1. Home
  2. FHN vs CGEN Comparison

FHN vs CGEN Comparison

Compare FHN & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Horizon Corporation

FHN

First Horizon Corporation

HOLD

Current Price

$24.46

Market Cap

12.3B

Sector

Finance

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$2.48

Market Cap

191.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FHN
CGEN
Founded
1864
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.3B
191.1M
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
FHN
CGEN
Price
$24.46
$2.48
Analyst Decision
Buy
Strong Buy
Analyst Count
19
2
Target Price
$26.24
$5.00
AVG Volume (30 Days)
3.7M
300.0K
Earning Date
04-15-2026
05-18-2026
Dividend Yield
2.79%
N/A
EPS Growth
37.50
N/A
EPS
1.07
N/A
Revenue
$3,419,000,000.00
N/A
Revenue This Year
$7.57
N/A
Revenue Next Year
$4.07
$75.09
P/E Ratio
$22.97
N/A
Revenue Growth
7.18
N/A
52 Week Low
$19.80
$1.30
52 Week High
$26.56
$3.24

Technical Indicators

Market Signals
Indicator
FHN
CGEN
Relative Strength Index (RSI) 45.03 46.09
Support Level $24.48 $2.23
Resistance Level $24.92 $2.54
Average True Range (ATR) 0.38 0.12
MACD 0.02 -0.03
Stochastic Oscillator 63.56 4.04

Price Performance

Historical Comparison
FHN
CGEN

About FHN First Horizon Corporation

First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets. The Wholesale segment delivers industry-specific products and services, while the Corporate segment provides internal support functions like finance, risk, and audit.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Share on Social Networks: